Literature DB >> 2328206

Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease.

R N Damle1, R J Tatake, S H Advani, S G Gangal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2328206      PMCID： PMC1971299          DOI： 10.1038/bjc.1990.88

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  22 in total

1.  Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease.

Authors:  D C Case; J A Hansen; E Corrales; C W Young; B Dupont; C M Pinsky; R A Good
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

Review 2.  The immune derangement in Hodgkin's disease.

Authors:  S Romagnani; P L Ferrini; M Ricci
Journal:  Semin Hematol       Date:  1985-01       Impact factor: 3.851

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Impairment of T lymphocyte colony formation in Hodgkin's disease: effect of soluble inhibitory factors on normal T lymphocyte colony formation potential.

Authors:  R Mukhopadhyaya; S H Advani; S G Gangal
Journal:  Acta Haematol       Date:  1983       Impact factor: 2.195

5.  Lymphoid subpopulations of peripheral blood and spleen in untreated Hodgkin's disease.

Authors:  M R Posner; E L Reinherz; J Breard; L M Nadler; D S Rosenthal; S F Schlossman
Journal:  Cancer       Date:  1981-09-01       Impact factor: 6.860

Review 6.  Hodgkin's disease: biology, treatment, prognosis.

Authors:  H S Kaplan
Journal:  Blood       Date:  1981-05       Impact factor: 22.113

7.  Association of an interleukin abnormality with the T cell defect in Hodgkin's disease.

Authors:  R J Ford; J Tsao; N M Kouttab; C G Sahasrabuddhe; S R Mehta
Journal:  Blood       Date:  1984-08       Impact factor: 22.113

8.  Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.

Authors:  K W Zamkoff; W G Reeves; F P Paolozzi; B J Poiesz; R L Comis; R H Tomar
Journal:  Clin Immunol Immunopathol       Date:  1985-04

9.  Comparison of the biological activities of human recombinant interleukin-2(125) and native interleukin-2.

Authors:  M V Doyle; M T Lee; S Fong
Journal:  J Biol Response Mod       Date:  1985-02

10.  Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease.

Authors:  G Pizzolo; M Chilosi; G Semenzato; F Caligaris-Cappio; L Fiore-Donati; G Perona; G Janossy
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640
View more
  3 in total

1.  Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease.

Authors:  R N Damle; S H Advani; S G Gangal
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.

Authors:  N Rajaram; R J Tatake; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

3.  Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.

Authors:  Elisabeth Oelmann; Harald Stein; Wolfgang E Berdel; Hermann Herbst
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.